Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 131 results for "Byetta"

Human medicines European public assessment report (EPAR): By...

This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 month ago

AstraZeneca Pharmaceuticals' Trademark Application for "BYETTA A SU LADO" Filed

By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "BYETTA A SU LADO" by Marc Stanislawczyk, representing AstraZeneca ...
 Pharmacy Choice4 weeks ago

Legal-Bay Lawsuit Settlement Funding Cautions Boaters in light of Jose Fernandez Death

MIAMI, Sept. 29, 2016 /PRNewswire/ -- , The Lawsuit Settlement Funding Company, a leader in lawsuit funding services and excellent customer service, urges boaters and ship travelers to take extra caution on the water ways in light of the tragic ...
 International Business Times1 day ago
[x]  

Researchers Model Possible Test for Early Parkinson's Diagnosis

Researchers may have found a test to diagnoseneurological disorders such as Parkinson's disease earlier, according to a new study published in the journal Physical Review Applied . The study, Fluctuations in Protein Aggregation: Design of ...
 Parkinson'sNewsToday.com2 days ago

Pharmacologic Management of Type 2 Diabetes Mellitus: Part 1

Clipper Young , PharmD, MPH, Assistant Professor, Touro University California College of Osteopathic Medicine (TUCCOM), College of Pharmacy, Vallejo, CA Joy Dugan , PA-C, MPH, Outpatient Clinical Instructor — Adjunct Assistant Professor, ...
 AHC Media3 days ago

PharmaPoint: Type 2 Diabetes - Global Drug Forecast valued at $58.7 billion by 2025 and Market Analysis

Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share, says GlobalData The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies ...
 Before It's News4 days ago Major players in Type II diabetes shifting focus to pricing to maintain market share  Express Pharma2 months ago The global type 2 diabetes market is projected to reach $58.7bn by 2025  CPhI.cn2 months ago

Antares Pharma Announces Completion of the QuickShot Testosterone Clinical Program

EWING, N.J., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced safety results from the dose-blinded, multiple-dose, concentration-controlled, 26-week phase 3 study of QuickShot® Testosterone (QST) administered ...
 Stockwatch1 week ago Antares Pharma To Present At The Healthcare Conference  BioSpace1 week ago Antares Pharma to Present at the Ladenburg Thalmann 2016 Healthcare Conference  Stockwatch1 week ago ANTARES PHARMA : Announces Completion of the QuickShot Testosterone Clinical Program  4 Traders1 week ago
[x]  

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Browse Report Summary with TOC @ http://www.reportbazzar.com/product/type-2-diabetes-mellitus-therapeutics-in-asia-pacific-markets-to-2021-increasing-usage-of-newer-therapies-and-expanding-treatment-population-to-encourage-robust-growth/ Summary ...
 MyNewsDesk1 week ago
Freshnews.com

Phase III Combination Trial of BYDUREON and FARXIGA Shows Significant Blood Sugar Reduction in Patients with Type 2 Diabetes

WILMINGTON, Del.--( BUSINESS WIRE )--Positive results from the Phase III DURATION-8 trial demonstrated that BYDUREON (exenatide extended-release) for injectable suspension 2 mg once-weekly in combination with FARXIGA (dapagliflozin) 10 mg once-daily ...
 Business Wire2 weeks ago AstraZeneca PLC Release: Phase III Combination Trial Of BYDUREON And FARXIGA Shows Significant Blood Sugar Reduction In Patients With Type 2 Diabetes  BioSpace1 week ago ASTRAZENECA : Phase III Combination Trial of BYDUREON and FARXIGA Shows Significant Blood Sugar Reduction in Patients with Type 2 Diabetes  4 Traders2 weeks ago
[x]  

Reduction in Production Costs Poised to Impel Sales of Peptide Therapeutics, reports TMR

The global peptide therapeutics market is highly fragmented, with the top three players representing nearly 52% of the overall market in 2013. The three leaders in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceuticals Co. Ltd., ...
 PharmiWeb2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less